EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
170 hedge funds and large institutions have $853M invested in Eagle Pharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 55 increasing their positions, 58 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
10% less capital invested
Capital invested by funds: $947M → $853M (-$94.6M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
170
Holding in Top 10
4
Calls
$5.53M
Puts
$5.04M
Top Buyers
| 1 | +$27M | |
| 2 | +$9.62M | |
| 3 | +$6.84M | |
| 4 |
PP
PDT Partners
New York
|
+$5.65M |
| 5 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$4.67M |
Top Sellers
| 1 | -$11.9M | |
| 2 | -$11.1M | |
| 3 | -$7.82M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$7.75M |
| 5 |
GAM
Gotham Asset Management
New York
|
-$6.67M |